SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Publications

Scientific work published in peer-reviewed journals in the years 2004 - present:

 

 

2017

 

Bankwitz D, Doepke M, Hueging K, Weller R, Bruening J, Behrendt P, Lee JY, Vondran FWR, Manns MP, Bartenschlager R, Pietschmann T.

Maturation of secreted HCV particles by incorporation of secreted apoE protects from antibodies by enhancing infectivity.

J Hepatol. 2017 Apr 21.

 

Vondran FWR, Oldhafer F, Ringe KI, Wirth TC, Kleine M, Jäger MD, Klempnauer J, Bektas H.

Associating Liver Partition and Portal vein ligation for Staged hepatectomy after pre-operative chemotherapy.

ANZ J Surg. 2017 Apr 16.

 

Westhaus S, Deest M, Nguyen AT, Stanke F, Heckl D, Costa R, Schambach A, Manns MP, Berg T, Vondran FW, Sarrazin C, Ciesek S, von Hahn T.

Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.

J Hepatol. 2017 Mar 28.

 

Lempp FA, Wiedtke E, Qu B, Roques P, Chemin I, Vondran FW, Le Grand R, Grimm D, Urban S.

Sodium taurocholate cotransporting polypeptide is the limiting host factor of Hepatitis B Virus infection in macaque and pig hepatocytes.

Hepatology. 2017 Feb 13.

 

 

2016

 

Harak C, Meyrath M, Romero-Brey I, Schenk C, Gondeau C, Schult P, Esser-Nobis K, Saeed M, Neddermann P, Schnitzler P, Gotthardt D, Perez-Del-Pulgar S, Neumann-Haefelin C, Thimme R, Meuleman P, Vondran FW, Francesco R, Rice CM, Bartenschlager R, Lohmann V.

Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture.

Nat Microbiol. 2016 Dec 19;2:16247.

 

Siddharta A, Pfaender S, Malassa A, Doerrbecker J, Anggakusuma, Engelmann M, Nugraha B, Steinmann J, Todt D, Vondran FW, Mateu-Gelabert P, Goffinet C, Steinmann E.

Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs

Sci Rep. 2016 Nov 18;6:36619.

 

Vondran FWR, Schumacher C, Johanning K, Hartleben B, Knitsch W, Wiesner O, Jaeckel E, Manns MP, Klempnauer J, Bektas H, Lehner F.

Application of the liver maximum function capacity test (LiMAx) in acute liver failure – A helpful tool for decision-making in liver transplantation?

Case Rep Transplant. 2016; 2016:7074636.

 

Cammann S, Timrott K, Vonberg R-P, Vondran FWR, Schrem H, Suerbaum S, Klempnauer J, Bektas H, Kleine M.

Cholangitis in the postoperative course after biliodigestive anastomosis.

Langenbeck Arch Surg. 2016 Aug; 401(5):715-24.

 

Van ND, Falk CS, Sandmann L, Vondran FW, Helfritz F, Wedemeyer H, Manns MP, Ciesek S, von Hahn T.

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators.

Gut. 2016 Jun;65(6):1015-23.

 

Oldhafer F, Ringe KI, Timrott K, Kleine M, Ramackers W, Cammann S, Jäger MD, Klempnauer J, Bektas H, Vondran FWR. 

Monitoring of liver function in a 73-year old patient undergoing `Associating Liver Partition and Portal vein ligation for Staged hepatectomy`: Case report applying the novel liver maximum function capacity test.

Patient Saf Surg. 2016 Jun 10;10:16.

 

Jäger MD, Vondran FW, Ramackers W, Röseler T, Schlitt HJ, Bektas H, Klempnauer J, Timrott K.

A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.

PLoS One. 2016 May 3;11(5):e0154682.

 

Vieyres G, Welsch K, Gerold G, Gentzsch J, Kahl S, Vondran FW, Kaderali L, Pietschmann T. ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production.

PLoS Pathog. 2016 Apr 28;12(4):e1005568.     

 

Oldhafer F, Bock M, Falk CS, Vondran FW.

Immunological aspects of liver cell transplantation.

World J Transplant. 2016 Mar 24;6(1):42-53. Review.

 

Kaltenborn A, Matzke S, Kleine M, Krech T, Ramackers W, Vondran FW, Klempnauer J, Bektas H, Schrem H.

Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms.

J Surg Oncol. 2016 Feb;113(2):194-202.

 

Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, Schang LM, Kirschning A, Müller R, Guzman CA, Kaderali L, Randall G, Meuleman P, Ploss A, Pietschmann T.

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

Hepatology. 2016 Jan;63(1):49-62.

 

 

2015

 

Oldhafer F, Ringe KI, Timrott K, Kleine M, Ramackers W, Cammann S, Jäger MD, Klempnauer J, Bektas H, Vondran FW.

Intraoperative Conversion to ALPPS in a Case of Intrahepatic Cholangiocarcinoma.

Case Rep Surg. 2015;2015:273641.

 

Vondran FW, Wintterle S, Bräsen JH, Haller H, Klempnauer J, Richter N, Lehner F, Schiffer M.

[Transplant Surgeon Meets Nephrologist: Important Nephrological Aspects Before and After Kidney or Liver Transplantation].

Zentralbl Chir. 2015 Nov 12.

 

Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martinez JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J.

Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.

J Hepatol. 2015 Oct;63(4):813-21. doi: 10.1016/j.jhep.2015.06.002.

 

Lauber C, Vieyres G, Terczyńska-Dyla E, Anggakusuma, Dijkman R, Gad HH, Akhtar H, Geffers R, Vondran FW, Thiel V, Kaderali L, Pietschmann T, Hartmann R.

Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells.

Genes Immun. 2015 Sep;16(6):414-21. doi: 10.1038/gene.2015.23.

 

Hadamitzky M, Bösche K, Wirth T, Buck B, Beetz O, Christians U, Schniedewind B, Lückemann L, Güntürkün O, Engler H, Schedlowski M.

Memory-updating abrogates extinction of learned immunosuppression.

Brain Behav Immun. 2015 Sep 18. pii: S0889-1591(15)30017-9.

 

Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E.

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.

Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913.

 

Stöhr S, Costa R, Sandmann L, Westhaus S, Pfaender S, Anggakusuma, Dazert E, Meuleman P, Vondran FW, Manns MP, Steinmann E, von Hahn T, Ciesek S.

Host cell mTORC1 is required for HCV RNA replication.

Gut. 2015 Aug 14. pii: gutjnl-2014-308971.

 

Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, Schang LM, Kirschning A, Müller R, Guzman CA, Kaderali L, Randall G, Meuleman P, Ploss A, Pietschmann T.

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.

Hepatology. 2015 Aug 6. doi: 10.1002/hep.28111.

 

Gerold G, Meissner F, Bruening J, Welsch K, Perin PM, Baumert TF, Vondran FW, Kaderali L, Marcotrigiano J, Khan AG, Mann M, Rice CM, Pietschmann T.

Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry.

Cell Rep. 2015 Aug 4;12(5):864-78. doi: 10.1016/j.celrep.2015.06.063.

 

Ramackers W, Klose J, Tiede A, Werwitzke S, Rataj D, Friedrich L, Johanning K, Vondran FW, Bergmann S, Schuettler W, Bockmeyer CL, Becker JU, Klempnauer J, Winkler M.

Effect of TNF-alpha blockade on coagulopathy and endothelial cell activation in xenoperfused porcine kidneys.

Xenotransplantation. 2015 Jul-Aug;22(4):284-94.

 

Hueging K, Weller R, Doepke M, Vieyres G, Todt D, Wölk B, Vondran FW, Geffers R, Lauber C, Kaderali L, Penin F, Pietschmann T.

Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.

PLoS One. 2015 Jul 30;10(7):e0134529. doi: 10.1371/journal.pone.0134529.

 

Timrott K, Vondran FW, Bektas H, Klempnauer J, Jäger MD.

Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties.

PLoS One. 2015 Apr 2;10(3):e0119950.

 

Van ND, Falk CS, Vondran FW, Helfritz F, Wedemeyer H, Manns MP, Ciesek S, von Hahn T.

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators.

Gut. 2015 Mar 23. pii: gutjnl-2014-308003.

 

Höing K, Ringe KI, Bektas H, Klempnauer J, Jäger MD.

Preduodenal superior mesenteric vein and Whipple procedure with vascular reconstruction-A case report.

Int J Surg Case Rep. 2015 Mar 24;10:107-110.

 

Gong X, Gao Y, Guo G, Vondran FW, Schwartlander R, Efimova E, Pless G, Sauera IM, Neuhaus P.

Effect of matrine on primary human hepatocytes in vitro.

Cytotechnology. 2015 Mar;67(2):255-65.

 

Özdemir M, Ringe KI, Schrem H, Kleine M, Meyer Zu Vilsendorf A, Klempnauer J, Lehner F, Jäger M, Bektas H.

A case of successful renal transplantation for hydatid disease after surgical treatment of disseminated cysts.

Transpl Infect Dis. 2015 Feb 19. [Epub ahead of print]

 

Veloso Alves Pereira I, Buchmann B, Sandmann L, Sprinzl K, Schlaphoff V, Döhner K, Vondran F, Sarrazin C, Manns MP, Pinto Marques Souza de Oliveira C, Sodeik B, Ciesek S, von Hahn T.

Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).

PLoS One. 2015 Feb 3;10(2):e0117152.

 

Bektas H, Yeyrek C, Kleine M, Vondran FW, Timrott K, Schweitzer N, Vogel A, Jäger MD, Schrem H, Klempnauer J, Kousoulas L.

Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience.

J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):131-7.

 

Sommer W, Knöfel AK, Izykowski N, Oldhafer F, Avsar M, Jonigk D, Warnecke G, Haverich A.

Physical exercise reduces transplant arteriosclerosis in a mouse aorta transplantation model.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):330-7.

 

Kaltenborn A, Hartmann C, Salinas R, Ramackers W, Kleine M, Vondran FW, Barthold M, Lehner F, Klempnauer J, Schrem H.

Risk factors for short- and long-term mortality in liver transplant recipients with MELD score ≥30.

Ann Transplant. 2015 Jan 29;20:59-69.

 

Kousoulas L, Vondran FW, Syryca P, Klempnauer J, Schrem H, Lehner F.

Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants.

J Transplant. 2015;2015:712049.

 

 

2014

 

Plege-Fleck A, Lieke T, Römermann D, Düvel H, Hundrieser J, Buermann A, Kraus L, Klempnauer J, Schwinzer R.

Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1.

Xenotransplantation. 2014 Nov-Dec;21(6):533-42.

 

Bektas H, Nadalin S, Szabo I, Ploder B, Sharkhawy M, Schmidt J.

Hemostatic efficacy of latest-generation fibrin sealant after hepatic resection: a randomized controlled clinical study.

Langenbecks Arch Surg. 2014 Oct;399(7):837-47.

 

Ramackers W, Klose J, Vondran FW, Schrem H, Kaltenborn A, Klempnauer J, Kleine M.

Species-specific regulation of fibrinogen synthesis with implications for porcine hepatocyte xenotransplantation.

Xenotransplantation. 2014 Sep-Oct;21(5):444-53.

 

Noyan F, Lieke T, Taubert R, Sievers M, Dywicki J, Hapke M, Falk CS, Manns MP, Jaeckel E, Hardtke-Wolenski M.

Naive tumour-specific CD4+ T cells were efficiently primed in acute lymphoblastic leukaemia.

Scand J Immunol. 2014 Sep;80(3):161-8.

 

Vondran FW, Timrott K, Kollrich S, Steinhoff AK, Kaltenborn A, Schrem H, Klempnauer J, Lehner F, Schwinzer R.

Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.

Clin Transplant. 2014 Sep;28(9):968-79.

 

Gehring G, Rohrmann K, Atenchong N, Mittler E, Becker S, Dahlmann F, Pöhlmann S, Vondran FW, David S, Manns MP, Ciesek S, von Hahn T.

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.

J Antimicrob Chemother. 2014 Aug;69(8):2123-31.

 

Timrott K, Vondran FW, Kleine M, Warnecke G, Haverich A, Lehner F, Klempnauer J.

The impact of abdominal complications on the outcome after thoracic transplantation--a single center experience.

Langenbecks Arch Surg. 2014 Aug;399(6):789-93.

 

Ramackers W, Friedrich L, Klose J, Vondran F, Bergmann S, Schüttler W, Johanning K, Werwitzke S, Trummer A, Bröcker V, Klempnauer J, Winkler M, Tiede A.

Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation.

Xenotransplantation. 2014 Jul-Aug;21(4):367-75.

 

Kleine M, Riemer M, Krech T, DeTemple D, Jäger MD, Lehner F, Manns MP, Klempnauer J, Borlak J, Bektas H, Vondran FW.

Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

PLoS One. 2014 Jul 7;9(7):e101386.

 

Schrem H, Kleine M, Lankisch TO, Kaltenborn A, Kousoulas L, Zachau L, Lehner F, Klempnauer J.

Long-term results after adult ex situ split liver transplantation since its introduction in 1987.

World J Surg. 2014 Jul;38(7):1795-806.

 

Kleine M, Worbs T, Schrem H, Vondran FW, Kaltenborn A, Klempnauer J, Förster R, Josenhans C, Suerbaum S, Bektas H.

Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes.

PLoS One. 2014 Jun 16;9(6):e99713.

 

Klose J, Stankov MV, Kleine M, Ramackers W, Panayotova-Dimitrova D, Jäger MD, Klempnauer J, Winkler M, Bektas H, Behrens GM, Vondran FW.

Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.

PLoS One. 2014 May 9;9(5):e95970.

 

Riedel G, Rüdrich U, Fekete-Drimusz N, Manns MP, Vondran FW, Bock M.

An extended ΔCT-method facilitating normalisation with multiple reference genes suited for quantitative RT-PCR analyses of human hepatocyte-like cells.

PLoS One. 2014 Mar 21;9(3):e93031.

 

Winny M, Paroglou V, Bektas H, Kaltenborn A, Reichert B, Zachau L, Kleine M, Klempnauer J, Schrem H.

Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis.

Surgery. 2014 Feb;155(2):271-9.

 

Vondran FW, Knitsch W, Krech T, Erichsen TJ, Sedlacek L, Abbas M, Klempnauer J, Bektas H, Lehner F, Kousoulas L.

Intestinal mucormycosis with Rhizopus microsporus after liver transplantation--successful treatment of a rare but life-threatening complication.

Transplantation. 2014 Jan 27;97(2):e11-3.

 

 

2013

 

Schrem H, Kurok M, Kaltenborn A, Vogel A, Walter U, Zachau L, Manns MP, Klempnauer J, Kleine M.

Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.

Liver Transpl. 2013 Nov;19(11):1252-61.

 

Hardtke-Wolenski M, Kraus L, Schmetz C, Trautewig B, Noyan F, Vondran FW, Bektas H, Klempnauer J, Jaeckel E, Lieke T.

Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth.

PLoS One. 2013 Oct 24;8(10):e78558.

 

Kleine M, Vondran FW, Johanning K, Timrott K, Bektas H, Lehner F, Klempnauer J, Schrem H.

Respiratory risk score for the prediction of 3-month mortality and prolonged ventilation after liver transplantation.

Liver Transpl. 2013 Aug;19(8):862-71.

 

Öllinger R, Mihaljevic AL, Schuhmacher C, Bektas H, Vondran F, Kleine M, Sainz-Barriga M, Weiss S, Knebel P, Pratschke J, Troisi RI.

A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery.

HPB (Oxford). 2013 Jul;15(7):548-58.

 

Kulik U, Bektas H, Klempnauer J, Lehner F.

Repeat liver resection for colorectal metastases.

Br J Surg. 2013 Jun;100(7):926-32.

 

Wahl K, Siegemund M, Lehner F, Vondran F, Nüssler A, Länger F, Krech T, Kontermann R, Manns MP, Schulze-Osthoff K, Pfizenmaier K, Bantel H.

Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.

Hepatology. 2013 Feb;57(2):625-36.

 

 

2012

 

Schrem H, Reichert B, Frühauf N, Kleine M, Zachau L, Becker T, Lehner F, Bektas H, Klempnauer J.

[Extended donor criteria defined by the German Medical Association : Study on their usefulness as prognostic model for early outcome after liver transplantation.]

Chirurg.2012 Nov; 83(11):980-8.

 

Lieke T, Ramackers W, Bergmann S, Klempnauer J, Winkler M, Klose J.

Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro.

BMC Cancer. 2012 Oct 11;12:466.

 

Kraus L, Trautewig B, Klempnauer J, Lieke T.

Naïve rat NK cells control the onset of T cell response.

PLoS One. 2012;7(10):e47074.

 

Vondran FW, Eiermann E, Thaiss F, Schwinzer R, Nashan B, Koch M.

Response to comments made by Atif on “In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor.

Transplantation. 2012 Sep 15;94(5):e27-8.

 

Schrem H, Reichert B, Frühauf N, Becker T, Lehner F, Kleine M, Bektas H, Zachau L, Klempnauer J.

The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.

Ann Transplant. 2012 Jul-Sep;17(3):5-13.

 

Schrem H, Reichert M, Reichert B, Becker T, Lehner F, Kleine M, Bektas H, Johanning K, Strassburg CP, Klempnauer J.

Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.

Langenbecks Arch Surg. 2012 Jun;397(5):717-26.

 

Stankov MV, Panayotova-Dimitrova D, Leverkus M, Vondran FW, Bauerfeind R, Binz A, Behrens GM.

Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.

AIDS. 2012 Aug 18.

 

Reichert B, Becker T, Weismüller TJ, Kleine M, Zachau L, Johanning K, Lehner F, Klempnauer J, Schrem H.

Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant labMELD-score ≥30.

Ann Transplant. 2012 Apr-Jun;17(2):11-7.

 

Vondran FW, Timrott K, Kollrich S, Klempnauer J, Schwinzer R, Becker T.

Decreased frequency of peripheral CD4+CD161+ Th17-precursor cells in kidney transplant recipients on long-term therapy with Belatacept.

Transpl Int 2012 Apr;25(4):455-63.

 

Kleine M, Schrem H, Vondran FWR, Krech T,  Klempnauer J, Bektas H.

Extended surgery in advanced pancreatic endocrine tumours.

Br J Surg. 2012 Jan;99(1):88-94.

 

Vondran FW, Eiermann E, Thaiss F, Schwinzer R, Nashan B, Koch M.

In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor.

Transplantation. 2012 Mar 27;93(6):e23-5.

 

Kemter E, Lieke T, Kessler B, Kurome M, Wuensch A, Summerfield A, Ayares D, Nagashima H, Baars W, Schwinzer R, Wolf E.

Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responses.

Xenotransplantation. 2012 Jan-Feb;19(1):40-51.

 

 

2011

 

Timrott K, Vondran FW, Jaeger MD, Gottlieb J, Klempnauer J, Becker T.

Incidence and outcome of abdominal surgical interventions following lung transplantation-a single center experience.

Langenbecks Arch Surg. 2011 Dec;396(8):1231-7.

 

Kleine M, Joahnning K, Kousoulas L, Schrem H, Lehner F, Bektas H, Klempnauer J, Kaaden S.

Observations with impact on the indication for kinetic therapy in critically ill liver transplant patients.

Ann Transplant. 2011 Oct-Dec;16(4):25-31.

 

Vondran FW, Timrott K, Tross J, Kollrich S, Gwinner W, Lehner F, Klempnauer J, Becker T, Schwinzer R.

Association of high anti-donor alloreactivity and low frequency of FoxP3 expressing cells prior to kidney transplantation with acute graft rejection.

Clin Transplant. 2011 Nov-Dec;25(6):905-14.

 

Lieke T, Nylén S, Eidsmo L, Schmetz C, Berg L, Akuffo H.

The interplay between Leishmania promastigotes and human Natural Killer cells in vitro leads to direct lysis of Leishmania by NK cells and modulation of NK cell activity by Leishmania promastigotes.

Parasitology. 2011 Sep 9:1-12.

 

Kulik U, Framke T, Grosshennig A, Ceylan A, Bektas H, Klempnauer J, Lehner F.

Liver resection of colorectal liver metastases in elderly patients.

World J Surg. 2011 Sep;35(9):2063-72.

 

Bektas H, Kleine M, Tamac A, Klempnauer J, Schrem H.

Clinical application of the hanover classification for iatrogenic bile duct lesions.

HPB Surg. 2011;2011:612384.

 

Lieke T, Gröbe D, Blanchard V, Grunow D, Tauber R, Zimmermann-Kordmann M, Jacobs T, Reutter W.

Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines.

Glycoconj J. 2011 Jan;28(1):31-7.

 

 

2010

 

G. Tasew, S. Nylen, T. Lieke, B. Lemu, H. Meless, N. Ruffin, D. Wolday, A. Asseffa, H. Yagita, S. Britton, H. Akuffo, F. Chiodi, L. Eidsmo.

Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

PLoS Negl. Trop. Dis. 4: e844.

 

Ding X, Reimann S, Timrott K, Gutenbrunner C, Schwarze M, Fischer MJ.

Comparison of the ICF core set for cardiopulmonary conditions in the acute hospital setting among different types of transplant patients.

Int J Rehabil Res. 2010 Dec;33(4):325-31.

 

Lehner F, Kulik U, Klempnauer J, Borlak J.

Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells.

PLoS One. 2010 Oct 13;5(10):e13344.

 

Lehner F, Kulik U, Klempnauer J, Borlak J.

Mapping of liver-enriched transcription factors in the human intestine.

World J Gastroenterol. 2010 Aug 21;16(31):3919-27.

 

Vondran FW, Timrott K, Tross J, Kollrich S, Schwarz A, Lehner F, Klempnauer J, Becker T, Schwinzer R.

Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.

Transpl Int. 2010 May 1;23(5):514-23.

 

 

2008

 

N. Raschzok, M.H. Morgul, J. Pinkernelle, F.W.R. Vondran, N. Billecke, N. Kammer, G. Pless, M.K. Adonopoulou, C. Leist, L. Stelter, U. Teichgraber, R. Schwartlander, I.M. Sauer

Imaging of Primary Human Hepatocytes Using Micron-Sized Iron Oxide Particles and Clinical Magnetic Resonance Tomography.

J Cell Mol Med. 2008 Aug, 12 (4): 1384-94.

 

Kleine M, Schrem H, Borlak J, Klempnauer J.

Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression.

Xenotransplantation. 2008 Jul-Aug;15(4):208-17.

 

M.H. Morgul, N.Raschzok, R. Schwartlander, F.W.R. Vondran, R. Michel, L. Stelter, J. Pinkernelle, A. Jordan, U. Teichgraber, I.M. Sauer.

Tracking of primary human hepatocytes with clinical MRI – initial results with Tat-peptide modified superparamagnetic iron oxide particles.

Int J of Artificial Organs 2008 Mar, 31(3):252-7.

 

F.W.R. Vondran, E. Katenz, R. Schwartlander, M.H. Morgul, N. Raschzok, X. Gong, X. Cheng, D. Kehr, I.M. Sauer.

Isolation of primary human hepatocytes after partial hepatectomy – Criteria for identification of the most promising liver specimen.

Artif. Organs 2008 Mar, 32(3): 205-13.

 

T. Lieke, S. Nylén, L. Eidsmo, W.R. McMaster, A.M. Mohammadi, A. Khamesipour, L. Berg, H. Akuffo.

Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.

Clin Exp. Immunol. 153: 221-230.

 

 

2007

 

Lehner F, Kulik U, Klempnauer J, Borlak J.

The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases.

FASEB J. 2007 May;21(7):1445-62.

 

F.W.R. Vondran*, E. Katenz*, R. Schwartlander, G. Pless, X. Gong, X. Cheng, P. Neuhaus, I.M. Sauer.

Cryopreservation of primary human hepatocytes – the benefit of trehalose as an additional cryoprotective agent.

Liver Transpl. 2007 Jan;13(1):38-45.

 

R. Schwartlander, J. Schmid, B. Brandenburg, E. Katenz, F.W.R. Vondran, G. Pless, X. Cheng, A. Pascher, P. Neuhaus, I.M. Sauer.

Continuously microscopically observed and process controlled cell culture within the SlideReactor – proof of a new concept for cell characterization.

Tissue Engineering 2007 Jan, 13(1):187-96.

 

Jäger MD, Liu JY, Timrott KF, Popp FC, Stoeltzing O, Lang SA, Piso P, Geissler EK, Schlitt HJ, Dahlke MH.

Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.

Exp Hematol. 2007 Jan., 35(1):164-70

 

 

2006

 

C. Furth, T. Denecke, J. Ruf, I. Steffen, T. Volker, D. Misch, F.W.R. Vondran, M. Plotkin, B. Stover, G. Henze, A.J. Lemke, H. Amthauer.

Correlative imaging strategies implementing CT, MRI and PET for staging of childhood Hodgkin´s disease.

J Pediatr Hema Oncol 2006

 

Schrem H, Kleine M, Borlak J, Klempnauer J.

Physiological incompatibilities of porcine hepatocytes for clinical liver support.

Liver Transpl. 2006 Dec;12(12):1832-40.

 

Koenecke C, Kleine M, Schrem H, Krug U, Nashan B, Neipp M, Ganser A, Hertenstein B, Klempnauer J.

Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation.

Int J Hematol. 2006 Apr;83(3):271-4.

 

T. Lieke, C. Steeg, S. Graefe, B. Fleischer, T. Jacobs.

Interactions of natural killer cells with Trypanosoma cruzi-infected fibroblasts.

Clin. Exp. Immunol. 145: 357-364.

 

 

2005

 

I.M. Sauer, R. Schwartlander, J. Schmid, E. Efimova, F.W.R. Vondran, D. Kehr, G. Pless, A. Spinelli, B. Brandenburg, E. Hildt, P. Neuhaus.

The SlideReactor - a simple hollow fiber based bioreactor suitable for light microscopy.

Artificial Organs 2005

 

 

2004

 

T. Lieke, S. Gräfe, U. Klauenberg, B. Fleischer, T. Jacobs.

NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by Perforin-independent mechanisms.

Inf. Immun. 72: 6817-6825.